Satish Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
as on 06-07-2024
- Paid Up Capital ₹ 0.10 M
as on 06-07-2024
- Company Age 30 Year, 8 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 2.43 Cr
as on 06-07-2024
- Revenue -88.10%
(FY 2020)
- Profit -97.60%
(FY 2020)
- Ebitda -124.45%
(FY 2020)
- Net Worth -247.74%
(FY 2020)
- Total Assets -20.01%
(FY 2020)
About Satish Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.43 Cr.
Chinmay Mokal, Rajendra Mokal, Satish Thorat, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24239MH1994PTC077527
- Company No.
077527
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Apr 1994
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Satish Pharma?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chinmay Mokal  | Director | 02-Apr-2020 | Current |
| Rajendra Mokal | Director | 02-Apr-2020 | Current |
| Satish Thorat | Director | 05-Apr-1994 | Current |
| Indubai Thorat | Director | 26-Feb-1999 | Current |
| Appasaheb Thorat | Director | 05-Apr-1994 | Current |
Financial Performance and Corporate Structure Insights of Satish Pharma.
Satish Pharma Pvt Ltd, for the financial year ended 2020, experienced significant reduction in revenue, with a 88.1% decrease. The company also saw a substantial fall in profitability, with a 97.6% decrease in profit. The company's net worth observed a substantial decline by a decrease of 247.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Satish Pharma?
In 2020, Satish Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vaishnavi Events And Hospitality LlpActive 1 year 3 monthsChinmay Mokal and Rajendra Mokal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 17 Sep 2012 | ₹2.30 Cr | Open |
The Mahanagar Co - Op. Bank Ltd. Creation Date: 09 Aug 2004 | ₹0.60 M | Open |
The Mahanagar Co - Op. Bank Ltd. Creation Date: 03 Aug 1999 | ₹0.70 M | Open |
How Many Employees Work at Satish Pharma?
Unlock and access historical data on people associated with Satish Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Satish Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Satish Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
